Amplifon closed the first quarter of the year with a Net income by 10 million euros, an improvement on the loss of 2,1 million euros recorded in the same period last year. THE revenues instead they increased by 2,4%, to 188,3 million, while the EBITDA it stood at 18,6 million, for an increase of 5% on an annual basis. After the communication of these numbers, the stock market share of the company that produces hearing aids rose by 3% in the Star segment, to 4,62 euros.
“For the continuation of 2014 – reads a note –, the group expects to confirm the gradual recovery of profitability in Europe, also benefiting from the restructuring measures carried out in 2013. Growth forecasts remain in the rest of the EMEA area , in America and in the Asia-Pacific area. The group will continue to pursue, also through external growth, the strategy of consolidating the market share in the countries in which it operates and to identify new investment opportunities”.
The company also specifies that "net financial debt, equal to 287,9 million euros, is up slightly compared to 275,4 million euros at 31 December 2013 due to the seasonality of working capital, but improves by 31 million euros compared to the same period of the previous year”.
